Replek, one of the leading pharma companies in North Macedonia, invested over 2 million EUR in a new pharmaceutical manufacturing unit by Marchesini Group S.p.A.
As official representatives of Marchesini, EuroCons Group, was part of the project โ ๐ถ๐ป๐๐๐ฎ๐น๐น๐ฎ๐๐ถ๐ผ๐ป ๐ผ๐ณ ๐๐ต๐ฒ ๐ป๐ฒ๐ ๐ฝ๐ฟ๐ผ๐ฑ๐๐ฐ๐๐ถ๐ผ๐ป ๐น๐ถ๐ป๐ฒ ๐ฒ๐ป๐ฎ๐ฏ๐น๐ถ๐ป๐ด ๐ณ๐ฎ๐๐ ๐ฎ๐ป๐ฑ ๐ฝ๐ฟ๐ฒ๐ฐ๐ถ๐๐ฒ ๐ฏ๐น๐ถ๐๐๐ฒ๐ฟ๐ถ๐ป๐ด, ๐ฐ๐ฎ๐ฟ๐๐ผ๐ผ๐ป๐ถ๐ป๐ด ๐ฎ๐ป๐ฑ ๐๐ฒ๐ฟ๐ถ๐ฎ๐น๐ถ๐๐ฎ๐๐ถ๐ผ๐ป โ up to 220 blisters per minute. In addition, Biro Plus, ECG member company, was in charge of architectural design for over 400m2 of clean rooms within the project.
The new production until will bring the following benefits to Replek:
โ๏ธ Production capacity for primary and secondary packaging of solid pharmaceutical forms increased by 25%
โ๏ธ Real-time quality control through built-in advanced systems and artificial intelligence
โ๏ธ Automation and standards have been raised to a level of global competitiveness
โ๏ธ Increases operational efficiency and achieves further compliance with the highest standards of quality and safety
The Replek CEO Dusan Pecovski , the Prime Minister of North Macedonia Hristijan Mickoski as well as the Minister of Health Azir Aliu and other guests were present at the inauguration of the new unit, which was highlighted as a significant milestone in the companyโs growth and long-term sustainability.
Kudos to our partners from Replek and Marchesini, as well as our colleagues Dragan Kesic, Vasilije Randelj and Ivan Robulj for successfully completing the project of modernization of the Replekโs production process!
